EurekAlert!

C-Path concludes 2025 Global Impact Conference with progress across rare diseases, neurology and pediatrics

Global regulators, industry leaders, scientists, and patient advocates set near-term commitments on early interception, trial modernization, and patient-first evidence. WASHINGTON, Sept. 11, 2025 ...
News Medical

C-Path supports innovative ALS, neurodegenerative disease research with new grant

Critical Path Institute's (C-Path) Translational Therapeutics Accelerator (TRxA) announced today a new research grant awarded to Daniela C. Zarnescu, Ph.D., Professor of Cellular and Molecular ...
EurekAlert!

C-Path’s Translational Therapeutics Accelerator marks record year with seven BRIDGe awards advancing potential therapies across cancer, infectious disease, neurology and ...

TUCSON, Ariz., September 4, 2025 —Critical Path Institute® (C-Path) announced today that its Translational Therapeutics Accelerator (TRxA) program has completed a record year of funding and mentorship ...
News Medical

C-Path announces important leadership appointments in neurology and Alzheimer's research

Critical Path Institute ® (C-Path) today announced key leadership appointments: Diane Stephenson, Ph.D., has been promoted to Vice President of Neurology, and Nadine Tatton, Ph.D., has been welcomed ...